Cite

HARVARD Citation

    Mösges, R. et al. (2018). A randomized, double‐blind, placebo‐controlled, dose‐finding trial with Lolium perenne peptide immunotherapy. Allergy. 73 (4), pp. 896-904. [Online]. 
  
Back to record